Wyman J F, Serve M P, Hobson D W, Lee L H, Uddin D E
Naval Medical Research Institute Detachment (Toxicology), Wright Patterson AFB, Ohio 45433-6503.
J Toxicol Environ Health. 1992 Oct;37(2):313-27. doi: 10.1080/15287399209531672.
Picric acid (2,4,6-trinitrophenol) is widely used in industry, by the military, and as a research/clinical chemistry reagent. Characterization of the toxicity of this chemical has been limited. Thus the acute toxicity, distribution, and metabolism of picric acid were investigated using Fischer 344 rats. The LD50 for picric acid following oral dosing of male and female rats was established as 290 and 200 mg/kg, respectively. Blood gas analysis indicated severe acidosis during acute intoxication. Metabolism of picric acid was limited to reduction of nitro groups to amines. Metabolites isolated from urine included N-acetylisopicramic acid (14.8%), picramic acid (18.5%), N-acetylpicramic acid (4.7%), and unidentified components (2.4%). Approximately 60% of the parent picric acid was excreted unchanged. The plasma half-life for picric acid was 13.4 h with a gut absorption coefficient (ka) of 0.069 h-1. Twenty-four hours following oral administration of [14C]picric acid (100 mg/kg), the primary depots of radioactivity (per gram tissue basis) were blood, spleen, kidney, liver, lung, and testes. Respective tissue/blood ratios were 0.37, 0.31, 0.28, 0.26, and 0.22. All other tissue assayed had partition ratios < 0.20, with brain and adipose tissue having the least amount of radioactivity. Tissue/blood ratios were essentially maintained over a 48-h postadministration period. Binding (in vitro) of [14C]picric acid to plasma proteins (whole blood preparations) demonstrated both high- and low-affinity binding sites, with dissociation constants of 3.18 x 10(-6) and 2.85 x 10(-4) M, respectively. The findings of this investigation provide information on the acute toxicity, metabolism, and distribution of picric acid, which can be used in risk assessment analyses and in the design of subchronic and chronic toxicity tests.
苦味酸(2,4,6-三硝基苯酚)在工业、军事领域广泛应用,并且用作研究/临床化学试剂。对这种化学品毒性的表征一直很有限。因此,使用Fischer 344大鼠研究了苦味酸的急性毒性、分布和代谢。雄性和雌性大鼠经口给药后苦味酸的半数致死量分别确定为290和200 mg/kg。血气分析表明急性中毒期间出现严重酸中毒。苦味酸的代谢仅限于硝基还原为胺。从尿液中分离出的代谢产物包括N-乙酰异苦氨酸(14.8%)、苦氨酸(18.5%)、N-乙酰苦氨酸(4.7%)和未鉴定成分(2.4%)。约60%的母体苦味酸原样排泄。苦味酸的血浆半衰期为13.4小时,肠道吸收系数(ka)为0.069 h-1。口服[14C]苦味酸(100 mg/kg)24小时后,放射性的主要蓄积部位(每克组织计)是血液、脾脏、肾脏、肝脏、肺和睾丸。各自的组织/血液比值分别为0.37、0.31、0.28、0.26和0.22。所有其他检测的组织分配比值<0.20,脑和脂肪组织的放射性最少。给药后48小时内组织/血液比值基本保持不变。[14C]苦味酸与血浆蛋白(全血制剂)的体外结合显示出高亲和力和低亲和力结合位点,解离常数分别为3.18×10(-6)和2.85×10(-4) M。本研究结果提供了有关苦味酸急性毒性、代谢和分布的信息,可用于风险评估分析以及亚慢性和慢性毒性试验的设计。